Romosozumab Antibody
Romosozumab is a humanized monoclonal antibody that inhibits sclerostin, promoting bone formation while reducing resorption. It is a key research tool for studying postmenopausal osteoporosis, with applications in both in vitro mechanistic studies and in vivo preclinical bone disease models.
Product Specifications
Product Name Alternative
AMG785, AMG-785, CDP7851, CDP-7851
Target
Wnt/beta-catenin
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Signal Transduction, Stem Cell & Developmental Biology
Concentration
6.15 mg/mL
Purity
95.00% (May vary between batches)
Molecular Weight
145.87 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.